Literature DB >> 699175

The major metabolite of aflatoxin B1 in the rat is a glutathione conjugate.

G H Degen, H G Neumann.   

Abstract

[14C]aflatoxin B1 (AFB1) was injected i.p. into female Wistar rats. Half of the dose was eliminated into the bile mostly as polar non-extractable metabolites. Among these a glutathione conjugate was the main component. The same conjugate was formed when rat liver postmitochondrial supernatant was incubated with AFB1 and [3H]glutathione. The conjugate was purified by ion exchange chromatography, gel-filtration and thin layer chromatography (TLC). It was tentatively identified as 2,3-dihydro-2-(S-glutathionyl)-3-hydroxy aflatoxin B1 (AFB1-GSH-conjugate). This structure was derived mainly from amino acid analysis, ultraviolet spectra and the enzymatic requirements for its formation in in vitro experiments. In the rat this detoxification product of the potentially ultimate reactive AFB1-epoxide constitutes about 10% of the administered dose and thus underlines the quantitative importance of this activating pathway.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699175     DOI: 10.1016/0009-2797(78)90129-1

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  12 in total

Review 1.  Metabolism and activation of chemical carcinogens.

Authors:  E K Weisburger
Journal:  Mol Cell Biochem       Date:  1980-09-15       Impact factor: 3.396

2.  Some mass-spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1.

Authors:  E J Moss; D J Judah; M Przybylski; G E Neal
Journal:  Biochem J       Date:  1983-01-15       Impact factor: 3.857

3.  Immunosuppressive effects of aflatoxin in growing rats.

Authors:  S Raisuddin; K P Singh; S I Zaidi; B N Paul; P K Ray
Journal:  Mycopathologia       Date:  1993-12       Impact factor: 2.574

4.  Effects of pre-treatment with aflatoxin on a second aflatoxin treatment in guinea pigs.

Authors:  W M Peden; J L Richard; J R Thurston; J L Sacks
Journal:  Mycopathologia       Date:  1987-08       Impact factor: 2.574

5.  Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B(1) in rats.

Authors:  S Gratz; M Täubel; R O Juvonen; M Viluksela; P C Turner; H Mykkänen; H El-Nezami
Journal:  Appl Environ Microbiol       Date:  2006-09-15       Impact factor: 4.792

Review 6.  Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease.

Authors:  P Khlangwiset; F Wu
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2010-07

7.  Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide.

Authors:  J D Hayes; D J Judah; L I McLellan; L A Kerr; S D Peacock; G E Neal
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

8.  Synergistic effect ofSacoglottis gabonensis bark extract.

Authors:  Z S Okoye; G E Neal
Journal:  Mycotoxin Res       Date:  1988-03       Impact factor: 3.833

9.  Positive correlation exists between glutathione S-transferase activity and aflatoxin formation in Aspergillus flavus.

Authors:  M Saxena; K G Mukerji; H G Raj
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

10.  Effects of neem leaf extract on production of aflatoxins and activities of fatty acid synthetase, isocitrate dehydrogenase and glutathione S-transferase in Aspergillus parasiticus.

Authors:  A Allameh; M Razzaghi Abyane; M Shams; M B Rezaee; K Jaimand
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.